SERAFINI, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 5.915
AS - Asia 5.405
EU - Europa 3.243
SA - Sud America 794
AF - Africa 146
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.520
Nazione #
US - Stati Uniti d'America 5.685
SG - Singapore 1.754
CN - Cina 1.002
IT - Italia 969
VN - Vietnam 966
HK - Hong Kong 711
BR - Brasile 617
RU - Federazione Russa 536
DE - Germania 365
IE - Irlanda 282
SE - Svezia 255
GB - Regno Unito 169
IN - India 166
CA - Canada 163
FR - Francia 157
ID - Indonesia 131
KR - Corea 115
FI - Finlandia 106
BD - Bangladesh 99
UA - Ucraina 83
TR - Turchia 76
AR - Argentina 65
ES - Italia 63
JP - Giappone 62
IQ - Iraq 61
ZA - Sudafrica 54
PK - Pakistan 53
NL - Olanda 49
PL - Polonia 42
MX - Messico 39
SA - Arabia Saudita 36
AT - Austria 29
CO - Colombia 29
CH - Svizzera 28
BE - Belgio 27
EC - Ecuador 27
IR - Iran 25
PH - Filippine 25
EG - Egitto 20
MA - Marocco 16
CL - Cile 15
DK - Danimarca 13
RO - Romania 13
VE - Venezuela 13
AU - Australia 12
ET - Etiopia 12
MY - Malesia 11
PY - Paraguay 11
TN - Tunisia 11
UZ - Uzbekistan 11
IL - Israele 10
JO - Giordania 10
LT - Lituania 10
TW - Taiwan 10
NO - Norvegia 9
NP - Nepal 9
CZ - Repubblica Ceca 8
JM - Giamaica 8
KE - Kenya 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
KZ - Kazakistan 7
TH - Thailandia 7
UY - Uruguay 7
LB - Libano 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
GR - Grecia 5
NI - Nicaragua 5
PE - Perù 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
AZ - Azerbaigian 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
AO - Angola 3
BG - Bulgaria 3
BO - Bolivia 3
CI - Costa d'Avorio 3
HN - Honduras 3
KG - Kirghizistan 3
LV - Lettonia 3
SC - Seychelles 3
AM - Armenia 2
GA - Gabon 2
GY - Guiana 2
HR - Croazia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
MN - Mongolia 2
NG - Nigeria 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BT - Bhutan 1
CM - Camerun 1
Totale 15.505
Città #
Singapore 1.060
Ann Arbor 820
Hong Kong 675
Ashburn 612
San Jose 567
Ho Chi Minh City 317
Milan 283
Dublin 277
Chandler 268
Hanoi 230
Hefei 208
Los Angeles 198
Fairfield 186
Houston 184
Frankfurt am Main 181
Wilmington 166
New York 164
Beijing 136
Santa Clara 134
Chicago 124
Dallas 120
Jakarta 106
Seoul 105
The Dalles 103
Woodbridge 99
Seattle 93
São Paulo 79
Toronto 77
Dearborn 76
Lauterbourg 67
Jacksonville 66
Shanghai 64
Council Bluffs 62
Princeton 61
Buffalo 60
Cambridge 57
Helsinki 51
Tokyo 49
Moscow 44
Munich 41
Bergamo 40
Denver 38
Haiphong 38
Johannesburg 35
Nanjing 33
Montreal 32
Orem 30
Turin 30
Monza 28
Warsaw 28
Nuremberg 27
Rome 27
Lawrence 26
Baghdad 25
Chennai 24
Da Nang 24
Hải Dương 24
Lappeenranta 24
London 24
Lahore 23
Atlanta 22
Brussels 21
Altamura 20
Guangzhou 20
Stockholm 20
Biên Hòa 19
Mumbai 19
Phoenix 19
Rio de Janeiro 19
Zurich 19
Lissone 18
San Diego 18
Ankara 17
Brooklyn 17
Turku 17
Bắc Ninh 16
Dhaka 16
Bologna 15
Jeddah 15
Poplar 15
Vienna 15
Belo Horizonte 14
Borgomanero 14
Brasília 14
Ottawa 14
Can Tho 13
Ha Long 13
Jinan 13
Mexico City 13
Tianjin 13
Amsterdam 12
Carate Brianza 12
Carrboro 12
Hyderabad 12
Naples 12
Ninh Bình 12
Riyadh 12
Sesto San Giovanni 12
Thái Nguyên 12
Addis Ababa 11
Totale 9.467
Nome #
Acute myeloid leukaemia niche regulates response to L-asparaginase 441
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 419
Zoledronic Acid in a Mouse Model of Human Fibrous Dysplasia: Ineffectiveness on Tissue Pathology, Formation of “Giant Osteoclasts” and Pathogenetic Implications 400
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 372
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice 364
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 354
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA 352
Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo 334
Location First: Targeting Acute Myeloid Leukemia Within Its Niche 332
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo 328
Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model 325
Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo 320
Characterization of Plated Lysate Cultured Mesenchymal Stromal Cells and Their Potential Use in Tissue-Engineered Osteogenic Devices for the Treatment of Bone Defects 298
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden 290
Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis 289
Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I 276
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden 269
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects 267
Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host disease 264
Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis 255
Catch me if you can: how AML and its niche escape immunotherapy 254
Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I 249
Generation of CIK cells co-expressing CXCR4 and CD33.CAR with improved homing and antitumor activity for AML 249
Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential 247
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 244
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia 244
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia 244
Cellule CD33.CAR-CIK ingegnerizzate per co-esprimere il recettore CXCR4 al fine di aumentare la capacità di migrazione all’interno della nicchia midollare nella leucemia mieloide acuta 244
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability 241
Combining the expression of CD33.CAR and CXCR4 to augment CAR-CIKs homing to bone marrow niche and leukemic stem cell eradication in acute myeloid leukemia 240
Isolation of single circulating trophoblasts from maternal circulation for noninvasive fetal copy number variant profiling 236
Combining the Expression of CD33.CAR and CXCR4 to Increase CAR-CIK Cell Homing to Bone Marrow Niche and Leukemic Stem Cell Eradication in Acute Myeloid Leukemia 231
CARs are sharpening their weapons 230
Functional transfer of CD40L gene in human B-cell precursor ALL blasts by second-generation SIN lentivectors 228
Bone marrow mesenchymal stromal cells support translation in refractory acute myeloid leukemia 217
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis 214
Hurler disease bone marrow stromal cells exhibit altered ability to support osteoclast formation 214
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche 213
Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia 213
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis 211
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency 209
Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better? 209
AML alters bone marrow stromal cell osteogenic commitment via Notch signaling 207
Detailed investigation of obstetric factors influencing isolation efficiency of fetal mesenchymal stem cells (FMSCS) from amniotic fluid and cord blood samples 207
Elongation factor 1 (EF1α) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis 200
Establishment of bone marrow and hematopoietic niches in vivo by reversion of chondrocyte differentiation of human bone marrow stromal cells 196
Ingegnerizzazione di cellule CD33.CAR-CIK con una variante gain-of-function del recettore CXCR4 per aumentarne migrazione e persistenza nella nicchia midollare 195
Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapies 191
A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies 188
Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells 187
An in vivo humanized model to study homing and sequestration of Plasmodium falciparum transmission stages in the bone marrow. 181
Acute Myeloid Leukemia (AML) immunotherapy: development of TIM3-CD33 targeted Dual CAR CIK cells for eradication of LSCs in the bone marrow niche 168
CD14 positive cells accelerate hematopoietic stem cell engraftment 156
Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery 151
MPSI Manifestations and Treatment Outcome: Skeletal Focus 146
Defective IL-10-mediated modulation of monocytes from autoimmune patients 136
mTORC1 hyperactivation arrests bone growth in lysosomal storage disorders by suppressing autophagy 125
GsαR201C and estrogen reveal different subsets of bone marrow adiponectin expressing osteogenic cells 113
Effect of Aplidin in acute lymphoblastic leukaemia cells 110
Morphological and immunophenotypical changes of human bone marrow adipocytes in marrow metastasis and myelofibrosis. 105
Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I 104
From stem cells to bone-forming cells 103
Solitary juvenile xanthogranuloma of the hypopharynx. Clinico-pathologic study in a child with β-Thalassemia Major and Cutaneous Mastocytosis 95
Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia 93
A human immunodeficiency virus type 1 pol gene-derived sequence (cPPT/CTS) increases the efficiency of transduction of human nondividing monocytes and T lymphocytes by lentiviral vectors 88
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2 86
Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches 82
Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future 81
Hematopoietic reconstitution by multipotent adult progenitor cells: Precursors to long-term hematopoietic stem cells 80
Molecular evidence of inefficient transduction of proliferating human B lymphocytes by VSV-pseudotyped HIV-1-derived lentivectors 78
Gene Therapy for Mucopolysaccharidoses: In Vivo and Ex Vivo Approaches 77
No identical "mesenchymal stem cells" at different times and sites: Human committed progenitors of distinct origin and differentiation potential are incorporated as adventitial cells in microvessels 74
Pluripotency in adult stem cells: State of the art 72
Lentiviral vectors show dramatically increased efficiency of transduction of human leukemic cell lines 70
A comprehensive study on the effect of alglucosidase alpha and immunomodulation on survival, motor and cardiac outcome, creatine kinase and antibody titers in classic infantile Pompe disease: the Monza experience 43
Effects of anti-RANKL, Zoledronate or combination therapy in a mouse model of fibrous dysplasia: a preclinical study 36
Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches 29
Totale 15.883
Categoria #
all - tutte 49.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.957


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021133 0 0 0 0 0 0 0 0 0 0 60 73
2021/2022624 63 61 63 54 44 50 25 19 34 43 42 126
2022/2023993 112 248 70 108 29 144 24 69 71 12 80 26
2023/20241.282 41 36 57 78 105 287 163 137 143 49 40 146
2024/20253.076 155 270 222 135 239 202 215 100 286 446 304 502
2025/20267.778 1.173 685 560 975 918 373 1.191 360 617 726 200 0
Totale 15.883